Siehe auch...
CRSP34 Antikörper
Empty Table Header | Produkt | Katnr. | Isotyp | Epitop | Anwendungen | Species | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|---|
CRSP34 Antikörper (B-7) | sc-390296 | mouse IgG2a κ | FL (h) | WB, IP, IF, ELISA | m, r, h | neu | ||
CRSP34 Antikörper (40.4) | sc-101187 | mouse IgG1 κ | 1-71 (h) | WB, IP, ELISA | m, r, h | neu | ||
CRSP34 Antikörper (A-2) | sc-390295 | mouse IgG1 κ | FL (h) | WB, IP, IF, ELISA | m, r, h | 1 |
CRSP34 CRISPR Knockout, HDR and Double Nickase Plasmids
Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|
CRSP34 CRISPR/Cas9 KO Plasmid (h) | sc-416989 | h | Gene Knockout | GFP | 0 | ||
CRSP34 HDR Plasmid (h) | sc-416989-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
CRSP34 Double Nickase Plasmid (h) | sc-416989-NIC | h | Gene Knockout | Puromycin | 0 | ||
CRSP34 Double Nickase Plasmid (h2) | sc-416989-NIC-2 | h | Gene Knockout | Puromycin | 0 |
CRSP34 CRISPR Activation Products
Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|
CRSP34 CRISPR Activation Plasmid (h) | sc-416989-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRSP34 CRISPR Activation Plasmid (h2) | sc-416989-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRSP34 Lentiviral Activation Particles (h) | sc-416989-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
CRSP34 Lentiviral Activation Particles (h2) | sc-416989-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 |
CRSP34 siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
---|---|---|---|---|---|---|---|
CRSP34 siRNA (h) | sc-38572 | h | Gene Silencing | N/A | 0 | ||
CRSP34 shRNA Plasmid (h) | sc-38572-SH | h | Gene Silencing | Puromycin | 0 | ||
CRSP34 shRNA (h) Lentivirale Partikel | sc-38572-V | h | Gene Silencing | Puromycin | 0 |